CSIMarket
 


Baxter International Inc   (BAX)
Other Ticker:  
 


Baxter International Inc 's EBITDA Margin by quarter

Trends, Rankings, Statistics



BAX EBITDA Margin (Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
Y / Y Revenue Change 2.83 % -1.56 % -3.55 % -1.72 % -1.04 %
Seq. Revenue Change 6.12 % -4.19 % 1.11 % 0.03 % 1.59 %
Revenue In Millions $3,812.00 $3,592.00 $3,749.00 $3,708.00 $3,707.00
EBITDA Margin 3.04 % 14.73 % 15.44 % 7.2 % 6.74 %
EBITDA Margin Total Ranking # 2227 # 1520 # 1410 # 2424 # 2518
EBITDA In Millions $116.00 $529.00 $579.00 $267.00 $250.00
Y / Y EBITDA Change -53.6 % 4.55 % -14.22 % - -66.17 %
Seq. EBITDA Change -78.07 % -8.64 % 116.85 % 6.8 % -50.59 %


Commenting Second Quarter 2024 EBITDA Margin
Company's EBITDA Margin sequentially deteriorated to 3.04 % due to increase in Operating Costs and despite Revenue increase of 6.12 % to $3,812 millions.

Company's EBITDA Margin in II. Quarter, was lower than company average.


Observing second quarter 2024 results within Medical Equipment & Supplies industry 68 other companies have achieved higher EBITDA Margin. While EBITDA Margin overall ranking has deteriorated compare to previous quarter from 1520 to 2227.
Learn about Operating Margin
BAX's EBITDA Margin second quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 69
Healthcare Sector # 185
Overall # 2225

EBITDA Margin Statistics
High Average Low
149.31 % 23.12 % 0.04 %
(Mar 31 2016)   (Sep 30 2015)




Other EBITDA Margin Profitability Ratios
BAX's Cumulative EBITDA Margin
Medical Equipment & Supplies Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
BAX's EBITDA Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for BAX's Competitors
EBITDA Margin Profit Margin for Baxter International Inc 's Suppliers
EBITDA Margin Profit Margin for BAX's Customers

You may also want to know
BAX's Annual Growth Rates BAX's Profitability Ratios BAX's Asset Turnover Ratio BAX's Dividend Growth
BAX's Roe BAX's Valuation Ratios BAX's Financial Strength Ratios BAX's EBITDA Growth
BAX's Roa BAX's Inventory Turnover Ratio BAX's Growth Rates BAX's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry EBITDA MarginJun 30 2024 MRQ EBITDAJun 30 2024 MRQ Revenue
Docgo Inc   7.97 %$ 13.142  Millions$ 164.950  Millions
Atrion Corporation  7.97 %$ 3.885  Millions$ 48.773  Millions
Henry Schein Inc   7.59 %$ 238.000  Millions$ 3,136.000  Millions
Dynatronics Corporation  7.54 %$ 0.313  Millions$ 4.148  Millions
Anika Therapeutics Inc   7.45 %$ 3.081  Millions$ 41.365  Millions
Vaso Corporation  7.40 %$ 1.492  Millions$ 20.151  Millions
Zynex inc   6.82 %$ 3.403  Millions$ 49.883  Millions
Inspire Medical Systems inc   6.27 %$ 12.229  Millions$ 195.042  Millions
Axonics Inc   5.74 %$ 6.550  Millions$ 114.143  Millions
Orasure Technologies Inc  5.46 %$ 2.932  Millions$ 53.689  Millions
Integra Lifesciences Holdings Corp  5.16 %$ 21.592  Millions$ 418.175  Millions
The Pennant Group Inc   4.69 %$ 7.913  Millions$ 168.745  Millions
Artivion Inc   3.56 %$ 3.464  Millions$ 97.324  Millions
Patterson Companies Inc   3.49 %$ 53.833  Millions$ 1,541.609  Millions
Owens and Minor inc   3.11 %$ 82.973  Millions$ 2,670.153  Millions
Baxter International Inc   3.04 %$ 116.000  Millions$ 3,812.000  Millions
Encision Inc   2.54 %$ 0.041  Millions$ 1.631  Millions
Warby Parker Inc   2.53 %$ 4.732  Millions$ 187.382  Millions
Privia Health Group Inc   2.34 %$ 9.882  Millions$ 422.326  Millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com